Ocata bought by Astellas of Japan: initial perspectives on end of an era - The Niche
Bombshell news in stem cell field as Ocata Therapeutics (OCAT; formerly Advanced Cell Technology or ACT) is reportedly to be acquired by Astellas Pharma.
Professor Paul Knoepfler, Ph.D.
